It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...
Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...
Thermo Fisher Scientific (TMO) announced earnings for its fourth quarter that increased from the same period last year and beat the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results